Delivery Order SPE2DB24D1007-SPE2DB25FCBSY
Award Date
5/9/25
Potential Completion Date
5/12/25
Potential Value
$7.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $14,581.38, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Ozempic, a diabetes medication, with an ultimate completion date of April 23, 2025. The contract is a Firm Fixed Price Delivery Order, without any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite...
This federal contract award, valued at $13,176.28, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml, a medication used to treat diabetes. The contract is a firm fixed-price agreement with an ultimate completion date of April 21, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,488.96 delivery order contract is for the supply of Ozempic 2 mg/dose (8 mg/3 ml) 3 ml, a medication used for diabetes management. The contract has a firm fixed price pricing type and an ultimate completion date of April 14, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract...
This federal contract award, valued at $85,838.21, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml, a diabetes medication. The contract is a firm fixed-price, non-set-aside award with a performance period through May 6, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award, valued at $7,703.58, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ozempic, a 1 mg/dose diabetes medication in 3 ml vials. This is a Firm Fixed Price Delivery Order contract with an ultimate completion date of October 29, 2024. The contract was not set aside for any specific business type. AmerisourceBergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,337.10 delivery order is for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml, a medication used for diabetes management. The contract has a firm fixed price and an ultimate completion date of July 18, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,122.93, is for the delivery of Ozempic 2 mg/dose (8 mg/3 ml) 3 ml, a diabetes medication. This is a firm fixed-price delivery order with a performance period ending on May 1, 2025. The contract is not set-aside and was awarded on April 30, 2025. Amerisourcebergen Drug Corp holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $3,684.32 firm-fixed-price delivery order is for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml, a medication used to treat diabetes. The contract has an ultimate completion date of August 2, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a $3,449.30 delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml, a medication used to treat diabetes. The award has an ultimate completion date of May 20, 2024 and a firm fixed price pricing type. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award, valued at $25,632.63, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order for the provision of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml, a diabetes treatment medication. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 17, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...